Evidence that the cells responsible for marrow fibrosis in a rat model for hyperparathyroidism (HPT) are preosteoblasts

Endocrinology

Volumn 146, Issue 9, 2005, Pages 4074-4081

  Lotinun, Sutada ^a   Sibonga, Jean D ^b   Turner, Russell T ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b UNIVERSITIES SPACE RESEARCH ASSOCIATION   (United States)

Author keywords

Bone formation; Bone histomorphometry; Bone matrix proteins; Gene expression; Parathyroid bone disease; Rat bone

Indexed keywords

OSTEOCALCIN; OSTEONECTIN; PARATHYROID HORMONE; THYMIDINE; TRANSCRIPTION FACTOR RUNX2; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; HORMONE DETERMINATION; HYPERPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; MYELOFIBROSIS; NONHUMAN; OSTEOBLAST; OSTEOCYTE; OSTEOID; PHENOTYPE; PRIORITY JOURNAL; RAT; TRABECULAR BONE;

NASA DISCIPLINE MUSCULOSKELETAL; NON-NASA CENTER;

ANIMALS; BODY WEIGHT; CORE BINDING FACTORS; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; FEMALE; HYPERPARATHYROIDISM; MYELOFIBROSIS; NEOPLASM PROTEINS; OSTEOBLASTS; OSTEOCALCIN; OSTEONECTIN; PARATHYROID HORMONE; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS; THYMIDINE; TRANSCRIPTION FACTORS; TRITIUM;

EID: 23844491569     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2005-0480     Document Type: Article

References (49)

1. Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J, Lindsay R 2001 Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 16:1846-1853
2. Sato M, Zeng GQ, Turner CH 1997 Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats. Endocrinology 138:4330-4337
3. Bereket A, Casur Y, Firat P, Yordam N 2000 Brown tumour as a complication of secondary hyperparathyroidism in severe long-lasting vitamin D deficiency rickets. Eur J Pediatr 159:70-73
4. rd LJ, Wermers RA, Crowson CS, O'Fallon W, Riggs B 1999 Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res 14:1700-1707
5. nd ed. San Diego: Academic Press; 349-360
6. th ed. Philadelphia: W.B. Saunders Company; 2103-2186
7. Sogaard CH, Wronski TJ, McOsker JE, Mosekilde L 1994 The positive effects of parathyroid hormone on femoral neck bone strength in ovariectomized rats is more pronounced than that of estrogen or bisphosphonates. Endocrinology 134:650-657
8. Mithal, A, Bandeira F, Meng X, Silverberg SJ, Shi Y, Mishra SK, Griz L, Macedo G, Celdas G, Bandeira C, Bilezikian JP, Rao SD 2001 Clinical presentation of primary hyperparathyroidism: India, Brazil, and China. In: Bilezikian JP, Marcus R, Levine MA, eds. The parathyroids: basic and clinical concepts. 2nd ed. San Diego:Academic Press; 375-386
9. Coburn JW, Salusky IB 2001 Renal bone diseases: clinical features, diagnosis and management. In: Bilezikian JP, Marcus R, Levine MA, eds. The parathyroids: basic and clinical concepts 2nd ed. San Diego:Academic Press; 635-661
10. Davies C, Demeure MJ, St. John A, Edis AJ 1990 Study of intact (1-84) parathyroid hormone secretion in patients undergoing parathyroidectomy. World J Surg 14:355-359
11. Dobnig H, Turner RT 1997 The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats. Endocrinology 138:4607-4612
12. Dobnig H, Turner RT 1995 Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136:3632-3638
13. Leaffer D, Sweeney M. Kellerman LA, Avnur Z, Krstenansky JL, Vickery BH, Caulfield JP 1995 Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1-34), and bovine PTH-(1-34). Endocrinology 136:3624-3631
14. Miller SC, de Saint-Georges L, Bowman BM, Jee WS 1989 Bone lining cells: structure and function. Scanning Microsc 3:953-960
15. Lotinun S, Sibonga JD, Turner RT 2003 Triazolopyrimidine (Trapidil), a platelet-derived growth factor antagonist, inhibits parathyroid bone disease in an animal model for chronic hyperparathyroidism. Endocrinology 144:2000-2007
16. Lotinun S, Evans GL, Bronk JT, Bolander ME, Wronski TJ, Ritman EL, Turner RT 2004 Continuous parathyroid hormone induces cortical porosity in the rat: Effects on bone turnover and mechanical properties. J Bone Miner Res in press.
17. Hock JM, Gera I 1992 Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res 7:65-72
18. Zhou H, Shen V, Dempster DW, Lindsay R 2001 Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen deficient rat. J Bone Miner Res 16:1300-1307
19. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610
20. Wewer UM, Albrechtsen R, Fisher LW, Young MF, Termine JD 1988 Osteonectin/SPARC/BM-40 in human decidua and carcinoma, tissues characterized by de novo formation of basement membrane. Am J Pathol. 132:345-355.
21. Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G 1999 A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 13:1025-36
22. Rader JI, Baylink DJ, Hughes MR, Safilian EF, Haussler MR 1979 Calcium and phosphorus deficiency in rats: effects on PTH and 1,25-dihydroxyvitamin D3. Am J Physiol 236:E118-E122
23. Shen V, Birchman R, Xu R, Lindsay R, Dempster DW 1995 Short-term changes in histomorphometric and biochemical turnover markers and bone mineral density in estrogen-and/or dietary calcium-deficient rats. Bone 16:149-156
24. Peacock M 1991 Interpretation of bone mass determinations as they relate to fracture: implications for asymtomatic primary hyperparathyroidism. J Bone Miner Res 6 (Suppl 2):S77-S82
25. Dempster DW, Parisien M, Silverberg SJ, Liang XG, Schnitzer M, Shen V, Shane E, Kimmel DB, Recker R, Lindsay R, Bilezikian JP 1999 On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab 84:1562-1566
26. Eriksen EF 2002 Primary hyperparathyroidism: lessons from bone histomorphometry. J Bone Miner Res 17(Suppl 2):N95-N97
27. Agarwal G, Mishra SK, Kar DK, Singh AK, Arya V, Gupta SK, Mithal A 2002 Recovery pattern of patients with osteitis fibrosa cystica in primary hyperparathyroidism after successful parathyroidectomy. Surgery 132:1075-1083
28. Chavda DV, Frock JT, Zielinski CM, Walla DJ, McGuire MH 1998 Reversal of the histology of bone after parathyroidectomy in patients with hyperparathyroidism. J South Orthop Assoc 7:65-71
29. Malluche HH, Mawad H, Monier-Faugere MC 2004 The importance of bone health in end-stage renal disease: out of the frying pan, into the fire? Nephrol Dial Transplant 19:9-13
30. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC 1999 Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104:439-446
31. Stanislaus D, Yang X, Liang JD, Wolfe J, Cain RL, Onyia JE, Falla N, Marder P, Bidwell JP, Queener SW, Hock JM 2000 In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment. Bone 27:209-218
32. Pun KK, Ho PW 1989 Identification and characterization of parathyroid hormone receptors on dog kidney, human kidney, chick bone and human dermal fibroblast. A comparative study of functional and structure properties. Biochem J 259:785-789
33. Yu J, Moon A, Kim HR 2001 Both platelet-derived growth factor receptor (PDGFR)-alpha and PDGFR-beta promote murine fibroblast cell migration. Biochem Biophys Res Commun 282:697-700
34. Ostman A, Heldin CH 2001 Involvement of platelet-derived growth factor in disease: development of specific antagonists. Adv Cancer Res 80:1-38
35. Onyia JE, Helvering LM, Gelbert L, Wei T, Huang S, Chen P, Dow ER, Maran A, Zhang M, Lotinun S, Lin X, Halladay DL, Miles RR, Kulkarni NH, Ambrose EM, Ma YL, Frolik CA, Sato M, Bryant HU, Turner RT 2005 A molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: An analysis by DNA microarray. J Cell Biochem 95:403-418
36. Kagan HM 2000 Intra- and extracellular enzymes of collagen biosynthesis as biological and chemical targets in the control of fibrosis. Acta Trop 77:147-152
37. Giampuzzi M, Botti G, Di Duca M, Arata L, Ghiggeri G, Gusmano R, Ravazzolo R, Di Donato A 2000 Lysyl oxidase activates the transcription activity of human collagen III promoter. Possible involvement of Ku antigen. J Biol Chem 275:36341-36349
38. Thomas G, Clayton A, Thomas J, Davies M, Steadman R 2003 Structural and functional changes in heparan sulfate proteoglycan expression associated with the myofibroblastic phenotype. Am J Pathology 162:977-989
39. Capolicchio G, Aitken KJ, Gu JX, Reddy P, Bagli DJ 2001 Extracellular matrix gene responses in a novel ex vivo model of bladder stretch injury. J Urol 165:2235-2240
40. Vleming LJ, Baelde JJ, Westendorp RG, Daha MR, van Es LA, Bruijn JA 1995 Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix. Clin Nephrol 44:211-219
41. Razzaque MS, Foster CS, Ahmed AR 2003 Role of collagen-binding heat shock protein 47 and transforming growth factor-beta1 in conjuctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 44:1616-1621
42. Stokes MB, Holler S, Cui Y, Hudkins KL, Eitner F, Fogo A, Alpers CE 2000 Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease. Kidney Int 57:487-498
43. Ducy P, Schinke T, Karsenty G 2000 The osteoblast: a sophisticated fibroblast under central surveillance. Science 289:1501-1504
44. Gonzalez EA, Lund RJ, Martin KJ, McCartney JE, Tondravi MM, Sampath TK, Hruska KA 2002 Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7. Kidney Int 61:1322-1331
45. Cowles EA, DeRome ME, Pastizzo G, Brailey LL, Gronowicz GA 1998 Mineralization and the expression of matrix proteins during in vivo bone development. Calcif Tissue Int. 62:74-82
46. Ishigaki R, Takagi M, Igarashi M, Ito K 2002 Gene expression and immunohistochemical localization of osteonectin in association with early bone formation in the developing mandible. Histochem J. 34:57-66
47. Luo Q, Kang Q, Si W, Jiang W, Park JK, Peng Y, Li X, Luu HH, Luo J, Montag AG, Haydon RC, He TC 2004 Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279:55958-55968
48. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR 1999 Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
49. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT 2003 Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841-846